Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
PUT
Boston Properties
BXP
$11.2B
| $2.92M | ﹤0.01% |
21,400
+8,800
| +70% | +$1.22M |
|
2927
CALL
Compass Minerals
CMP
$1.05B
| $2.91M | ﹤0.01% |
39,500
-2,700
| -6% | -$196K |
|
2928
PUT
Safety Insurance
SAFT
$1.52B
| $2.91M | ﹤0.01% |
43,300
+29,300
| +209% | +$1.91M |
|
|
FMI
2929
DELISTED
Foundation Medicine, Inc.
FMI
| $2.91M | ﹤0.01% |
124,632
+83,049
| +200% | +$1.89M |
|
|
CPPL
2930
PUT
DELISTED
Columbia Pipeline Partners LP
CPPL
| $2.91M | ﹤0.01% |
180,200
+65,300
| +57% | +$962K |
|
2931
SS&C Technologies
SSNC
$19.6B
| $2.91M | ﹤0.01% |
90,374
+28,151
| +45% | +$892K |
|
2932
PUT
ProShares VIX Mid-Term Futures ETF
VIXM
$154M
| $2.91M | ﹤0.01% |
63,600
+35,100
| +123% | +$1.69M |
|
2933
iShares US Consumer Staples ETF
IYK
$1.42B
| $2.9M | ﹤0.01% |
76,464
-13,725
| -15% | -$531K |
|
2934
Aon
AON
$74.2B
| $2.9M | ﹤0.01% |
25,800
| – | – |
|
|
HDV
2935
CALL
iShares Core High Dividend ETF
HDV
$15.2B
| $2.9M | ﹤0.01% |
178,500
+82,000
| +85% | +$1.35M |
|
2936
PUT
Albemarle
ALB
$16B
| $2.9M | ﹤0.01% |
33,900
-93,600
| -73% | -$7.71M |
|
2937
PUT
Churchill Downs
CHDN
$6.03B
| $2.9M | ﹤0.01% |
118,800
-20,400
| -15% | -$481K |
|
|
FPRX
2938
PUT
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.9M | ﹤0.01% |
55,200
-10,100
| -15% | -$482K |
|
|
ISIL
2939
CALL
DELISTED
Intersil Corp
ISIL
| $2.9M | ﹤0.01% |
132,000
-2,100
| -2% | -$36.4K |
|
2940
CALL
Dentsply Sirona
XRAY
$2.2B
| $2.89M | ﹤0.01% |
48,700
+9,600
| +25% | +$590K |
|
|
PACW
2941
DELISTED
PacWest Bancorp
PACW
| $2.89M | ﹤0.01% |
67,400
| – | – |
|
2942
PUT
M&T Bank
MTB
$34.5B
| $2.89M | ﹤0.01% |
24,900
+4,900
| +25% | +$569K |
|
2943
Citizens
CIA
$199M
| $2.89M | ﹤0.01% |
+308,804
| New | +$2.87M |
|
2944
CALL
Highwoods Properties
HIW
$3.46B
| $2.89M | ﹤0.01% |
+55,400
| New | +$2.95M |
|
2945
PUT
ProShares Ultra Financials
UYG
$840M
| $2.88M | ﹤0.01% |
119,100
+3,000
| +3% | +$71.8K |
|
2946
PUT
Strategy Inc
MSTR
$54.6B
| $2.88M | ﹤0.01% |
172,000
-134,000
| -44% | -$2.31M |
|
2947
PUT
iShares Preferred and Income Securities ETF
PFF
$13.1B
| $2.88M | ﹤0.01% |
72,900
-46,900
| -39% | -$1.87M |
|
2948
Children's Place
PLCE
$54.5M
| $2.88M | ﹤0.01% |
36,041
| – | – |
|
2949
CALL
Chemed
CHE
$6.8B
| $2.88M | ﹤0.01% |
20,400
+9,700
| +91% | +$1.35M |
|
|
KATE
2950
CALL
DELISTED
Kate Spade & Company
KATE
| $2.88M | ﹤0.01% |
167,900
-150,700
| -47% | -$2.92M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.